Gillard M - Search Results

1

Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells.

Gillard M, Van der Perren C, Massingham R, Chatelain P. Gillard M, et al. Inflamm Res. 2002 Apr;51 Suppl 1:S77-8. doi: 10.1007/pl00022457. Inflamm Res. 2002. PMID: 12013420 No abstract available.

2

Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).

Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P. Gillard M, et al. Mol Pharmacol. 2002 Feb;61(2):391-9. doi: 10.1124/mol.61.2.391. Mol Pharmacol. 2002. PMID: 11809864

3

Histamine H1 receptor antagonism by cetirizine in isolated guinea pig tissues: influence of receptor reserve and dissociation kinetics.

Christophe B, Carlier B, Gillard M, Chatelain P, Peck M, Massingham R. Christophe B, et al. Among authors: gillard m. Eur J Pharmacol. 2003 May 30;470(1-2):87-94. doi: 10.1016/s0014-2999(03)01781-3. Eur J Pharmacol. 2003. PMID: 12787835

4

Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.

Gillard M, Chatelain P. Gillard M, et al. Eur J Pharmacol. 2006 Jan 20;530(3):205-14. doi: 10.1016/j.ejphar.2005.11.051. Epub 2006 Jan 4. Eur J Pharmacol. 2006. PMID: 16388798

5

Major role for the carboxylic function of cetirizine and levocetirizine in their binding characteristics to human H1-histamine-receptors.

Gillard M, Van der Perren C, Moguilevsky N, Massingham R, Chatelain P. Gillard M, et al. Inflamm Res. 2002 Apr;51 Suppl 1:S79-80. doi: 10.1007/pl00022458. Inflamm Res. 2002. PMID: 12013421 No abstract available.

6

H1 antagonists: receptor affinity versus selectivity.

Gillard M, Christophe B, Wels B, Peck M, Massingham R, Chatelain P. Gillard M, et al. Inflamm Res. 2003 Apr;52 Suppl 1:S49-50. doi: 10.1007/s000110300050. Inflamm Res. 2003. PMID: 12755407 No abstract available.

7

The histamine H(1)-receptor antagonist cetirizine does not interact with bradykinin B(1) or B(2)-receptors in vitro.

Christophe B, Maleux MR, Gillard M, Chatelain P, Peck MJ, Massingham R. Christophe B, et al. Among authors: gillard m. Inflamm Res. 2004 Mar;53 Suppl 1:S81-2. doi: 10.1007/s00011-003-0339-9. Epub 2004 Mar 5. Inflamm Res. 2004. PMID: 15054630 No abstract available.

8

Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.

Gillard M, Benedetti MS, Chatelain P, Baltes E. Gillard M, et al. Inflamm Res. 2005 Sep;54(9):367-9. doi: 10.1007/s00011-005-1368-3. Inflamm Res. 2005. PMID: 16273334

9

Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain.

Gillard M, Fuks B, Michel P, Vertongen P, Massingham R, Chatelain P. Gillard M, et al. Eur J Pharmacol. 2003 Sep 30;478(1):1-9. doi: 10.1016/j.ejphar.2003.08.032. Eur J Pharmacol. 2003. PMID: 14555178

10

[3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.

Wolff C, Gillard M, Fuks B, Chatelain P. Wolff C, et al. Among authors: gillard m. Eur J Pharmacol. 2005 Jul 25;518(1):10-7. doi: 10.1016/j.ejphar.2005.06.005. Eur J Pharmacol. 2005. PMID: 16018996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters